Infection, Super Infection and Antimicrobial Management in ICU

Infection, Super Infection and Antimicrobial Management in ICU

EMERGING INFECTIOUS DISEASES--EPIDEMIOLOGY

Assessing the risk of difficult-to-treat bacterial superinfections, such as multidrug-resistant (MDR) Gram-negative bacilli, according to comorbidities, lung abnormalities or systemic diseases, the severity of pneumonia and the risks of drug-related effects are crucial points for the clinical management. Despite the wide—and not always appropriate—use of broad-spectrum antimicrobials, specific data about bacterial and fungal co-infection in COVID-19 patients are lacking, and confirmed evidence is urgently required to build prospective evidence and to support the development of antimicrobial policy and appropriate stewardship interventions. The present Special Issue aims to focus on the following key points: Importance of superinfections in COVID-19 patients who are typically characterized by immunosuppression related to viral infection, need for prolonged hospitalization, treatment with immunomodulatory therapies (steroids, monoclonal antibodies, etc.); Their impact on the outcome of a cohort of patients who are relatively young, with few comorbidities, but requiring prolonged invasive support; Incidence, characteristics and impact of bacterial infections caused by multidrug-resistant, Gram-negative pathogens in the context of COVID-19 disease; Incidence, characteristics and impact of fungal infections, such as the most known invasive aspergillosis but also candidemia and/or other fungal infections (e.g., mucormycosis); Antimicrobial surveillance, control and management measures as implemented on a local, national and international basis.

Brazzi, Luca (editor)
Montrucchio, Giorgia (editor)

https://directory.doabooks.org/handle/20.500.12854/113867

MDPI - Multidisciplinary Digital Publishing Institute

2023

Sulistiorini

https://creativecommons.org/licenses/by/4.0/

1. Mariateresa Ceparano, Antonio Sciurti, Claudia Isonne, Valentina Baccolini, Giuseppe
Migliara, Carolina Marzuillo, et al.
Incidence of Healthcare-Associated Infections in a Neonatal Intensive Care Unit before and
during the COVID-19 Pandemic: A Four-Year Retrospective Cohort Study
2. Christoph J. Leitl, Sandra E. Stoll,Wolfgang A.Wetsch, Tobias Kammerer, Alexander Mathes,
Bernd W. B¨ ottiger, et al.
Next-Generation Sequencing in Critically Ill COVID-19 Patients with Suspected Bloodstream
Infections: A Retrospective Cohort Study
3. Ines Gragueb-Chatti, Herv´e Hyvernat, Marc Leone, Geoffray Agard, No´emie Peres,
Christophe Guervilly, et al.
Incidence, Outcomes and Risk Factors of Recurrent Ventilator Associated Pneumonia in
COVID-19 Patients: A Retrospective Multicenter Study
4. Enrico Bussolati, Rosario Cultrera, Alessandra Quaranta, Valentina Cricca, Elisabetta
Marangoni, Riccardo La Rosa, et al.
Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription
Trends in Non-COVID19 Acute Respiratory Failure Patients
5. Romain Tortuyaux, Fr´ed´eric Wallet, Philippe Derambure and Saad Nseir
Bacterial Aspiration Pneumonia in Generalized Convulsive Status Epilepticus: Incidence,
Associated Factors and Outcome

Pdf

English

Textbooks

DOI
10.3390/books978-3-0365-8381-5